Literature DB >> 26104805

Cellular Uptake Mechanism of Paclitaxel Nanocrystals Determined by Confocal Imaging and Kinetic Measurement.

Yan Chen1, Tonglei Li.   

Abstract

Nanocrystal formulation has become a viable solution for delivering poorly soluble drugs including chemotherapeutic agents. The purpose of this study was to examine cellular uptake of paclitaxel nanocrystals by confocal imaging and concentration measurement. It was found that drug nanocrystals could be internalized by KB cells at much higher concentrations than a conventional, solubilized formulation. The imaging and quantitative results suggest that nanocrystals could be directly taken up by cells as solid particles, likely via endocytosis. Moreover, it was found that polymer treatment to drug nanocrystals, such as surface coating and lattice entrapment, significantly influenced the cellular uptake. While drug molecules are in the most stable physical state, nanocrystals of a poorly soluble drug are capable of achieving concentrated intracellular presence enabling needed therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26104805      PMCID: PMC4540733          DOI: 10.1208/s12248-015-9774-0

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  14 in total

1.  Synthesis and characterization of amphiphilic chitosan derivatives as a nano-carrier for paclitaxel delivery.

Authors:  Huofei Zhou; Xiudong Liu; Xin Guo; Nan Li; Weiting Yu; Ying Zhang; Xiaojun Ma
Journal:  J Control Release       Date:  2011-11-30       Impact factor: 9.776

2.  The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles.

Authors:  P Decuzzi; M Ferrari
Journal:  Biomaterials       Date:  2007-02-21       Impact factor: 12.479

3.  Hybrid nanocrystals: achieving concurrent therapeutic and bioimaging functionalities toward solid tumors.

Authors:  Rongsheng Zhao; Christin P Hollis; Hua Zhang; Lili Sun; Richard A Gemeinhart; Tonglei Li
Journal:  Mol Pharm       Date:  2011-08-10       Impact factor: 4.939

4.  Temperature dependence of endocytosis in renal epithelial cells in culture.

Authors:  Z Mamdouh; M C Giocondi; R Laprade; C Le Grimellec
Journal:  Biochim Biophys Acta       Date:  1996-07-25

5.  Paclitaxel loaded nano-aggregates based on pH sensitive polyaspartamide amphiphilic graft copolymers.

Authors:  Kwangwon Seo; Seung Woo Chung; Youngro Byun; Dukjoon Kim
Journal:  Int J Pharm       Date:  2011-12-31       Impact factor: 5.875

6.  Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.

Authors:  Mostafa Shahin; Afsaneh Lavasanifar
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

7.  Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.

Authors:  Emily Gullotti; Joonyoung Park; Yoon Yeo
Journal:  Pharm Res       Date:  2013-04-23       Impact factor: 4.200

Review 8.  Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

Authors:  Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil
Journal:  Adv Drug Deliv Rev       Date:  2009-04-17       Impact factor: 15.470

9.  Nano-formulation of paclitaxel by vitamin E succinate functionalized pluronic micelles for enhanced encapsulation, stability and cytotoxicity.

Authors:  Youhua Tao; Jianfeng Han; Xiaowen Wang; Huanyu Dou
Journal:  Colloids Surf B Biointerfaces       Date:  2012-09-06       Impact factor: 5.268

10.  Liposome formulation of paclitaxel with enhanced solubility and stability.

Authors:  Tao Yang; Fu-De Cui; Min-Koo Choi; Hongxia Lin; Suk-Jae Chung; Chang-Koo Shim; Dae-Duk Kim
Journal:  Drug Deliv       Date:  2007-07       Impact factor: 6.419

View more
  11 in total

1.  Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.

Authors:  Joonyoung Park; Bo Sun; Yoon Yeo
Journal:  J Control Release       Date:  2016-12-31       Impact factor: 9.776

Review 2.  Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.

Authors:  Zonghua Tian; Yaping Mai; Tingting Meng; Shijie Ma; Guojing Gou; Jianhong Yang
Journal:  AAPS PharmSciTech       Date:  2021-06-14       Impact factor: 3.246

3.  Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals.

Authors:  Bo Sun; Maie S Taha; Benjamin Ramsey; Sandra Torregrosa-Allen; Bennett D Elzey; Yoon Yeo
Journal:  J Control Release       Date:  2016-05-26       Impact factor: 9.776

4.  Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation.

Authors:  Ji Eun Park; Joonyoung Park; Yearin Jun; Yunseok Oh; Gongmi Ryoo; Yoo-Seong Jeong; Hytham H Gadalla; Jee Sun Min; Jung Hwan Jo; Myung Geun Song; Keon Wook Kang; Soo Kyung Bae; Yoon Yeo; Wooin Lee
Journal:  J Control Release       Date:  2019-04-04       Impact factor: 9.776

5.  A Smart Paclitaxel-Disulfiram Nanococrystals for Efficient MDR Reversal and Enhanced Apoptosis.

Authors:  Imran Shair Mohammad; Wei He; Lifang Yin
Journal:  Pharm Res       Date:  2018-02-27       Impact factor: 4.200

Review 6.  Performance Parameters and Characterizations of Nanocrystals: A Brief Review.

Authors:  Manasi M Chogale; Vinod N Ghodake; Vandana B Patravale
Journal:  Pharmaceutics       Date:  2016-08-30       Impact factor: 6.321

7.  Permeability Behavior of Nanocrystalline Solid Dispersion of Dipyridamole Generated Using NanoCrySP Technology.

Authors:  Ashish Girdhar; Poonam Singh Thakur; Sneha Sheokand; Arvind K Bansal
Journal:  Pharmaceutics       Date:  2018-09-17       Impact factor: 6.321

Review 8.  Understanding Critical Quality Attributes for Nanocrystals from Preparation to Delivery.

Authors:  Leena Peltonen; Clare Strachan
Journal:  Molecules       Date:  2015-12-12       Impact factor: 4.411

9.  Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacy.

Authors:  Zheng Zhai; Pengcheng Xu; Jun Yao; Ridong Li; Lidong Gong; Yuxin Yin; Zhiqiang Lin
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

10.  Preparation of parenteral nanocrystal suspensions of etoposide from the excipient free dry state of the drug to enhance in vivo antitumoral properties.

Authors:  Brice Martin; Johanne Seguin; Maxime Annereau; Thomas Fleury; René Lai-Kuen; Giovanni Neri; Anita Lam; Marcel Bally; Nathalie Mignet; Yohann Corvis
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.